Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex

Table 2

Formulation table for ODT’s using complexes prepared by lyophilisation method.

Formulations	Candesartan-β-cyclodextrin complex	Mannitol	Low HPC	Crosspovidone	Cross carmellose sodium	Sodium starch glycolate	Aspartame	Aerosil	Talc
F13	82	49	5	—	—	—	5	3	6
F14	82	46.5	7.5	—	—	—	5	3	6
F15	82	44	10	—	—	—	5	3	6
F16	82	49	—	5	—	—	5	3	6
F17	82	46.5	—	7.5	—	—	5	3	6
F18	82	44	—	10	—	—	5	3	6
F19	82	49	—	—	5	—	5	3	6
F20	82	46.5	—	—	7.5	—	5	3	6
F21	82	44	—	—	10	—	5	3	6
F22	82	49	—	—	—	5	5	3	6
F23	82	46.5	—	—	—	7.5	5	3	6
F24	82	44	—	—	—	10	5	3	6